- Home
- ABAT vs CLYM Comparison
ABAT vs CLYM Comparison
Compare ABAT & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- CLYM
- Stock Information
- Founded
- ABAT 2011
- CLYM 2018
- Country
- ABAT United States
- CLYM United States
- Employees
- ABAT N/A
- CLYM N/A
- Industry
- ABAT Metal Mining
- CLYM
- Sector
- ABAT Basic Materials
- CLYM
- Exchange
- ABAT Nasdaq
- CLYM NYSE
- Market Cap
- ABAT 87.2M
- CLYM 85.8M
- IPO Year
- ABAT N/A
- CLYM 2021
- Fundamental
- Price
- ABAT $1.41
- CLYM $1.20
- Analyst Decision
- ABAT
- CLYM
- Analyst Count
- ABAT 0
- CLYM 0
- Target Price
- ABAT N/A
- CLYM N/A
- AVG Volume (30 Days)
- ABAT 1.5M
- CLYM 145.4K
- Earning Date
- ABAT 05-16-2025
- CLYM 05-14-2025
- Dividend Yield
- ABAT N/A
- CLYM N/A
- EPS Growth
- ABAT N/A
- CLYM N/A
- EPS
- ABAT N/A
- CLYM N/A
- Revenue
- ABAT $1,857,877.00
- CLYM N/A
- Revenue This Year
- ABAT $31,748.62
- CLYM N/A
- Revenue Next Year
- ABAT N/A
- CLYM N/A
- P/E Ratio
- ABAT N/A
- CLYM N/A
- Revenue Growth
- ABAT N/A
- CLYM N/A
- 52 Week Low
- ABAT $0.73
- CLYM $1.05
- 52 Week High
- ABAT $4.11
- CLYM $9.58
- Technical
- Relative Strength Index (RSI)
- ABAT 54.09
- CLYM N/A
- Support Level
- ABAT $1.29
- CLYM N/A
- Resistance Level
- ABAT $1.42
- CLYM N/A
- Average True Range (ATR)
- ABAT 0.12
- CLYM 0.00
- MACD
- ABAT -0.02
- CLYM 0.00
- Stochastic Oscillator
- ABAT 43.03
- CLYM 0.00
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.